• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Medicare, Novo Nordisk A/S, Obesity, Ozempic (Drug), Prices (Fares, Fees and Rates), United States Politics and Government
←Social Media Users Shut Down GOP Senator Over His Out-Of-Control Disasters Claim
Seth Meyers Wants Biden To Do 1 ‘Wicked’ Thing At Donald Trump’s Inauguration→

More posts

  • WATCH: How a new drug could lengthen lives of pancreatic cancer patients

  • Candidates face off on affordability in final California gubernatorial debate

  • Read the full transcript: Secretary of State Marco Rubio interviewed by ‘NBC Nightly News’ anchor Tom Llamas

  • Claudine Longet, the French starlet who fatally shot Olympic skier Spider Sabich, dies at 84

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube